The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging information in targeted therapies, and answering patient questions in real-time.
In this video, from the ALK/ROS1 breakout session, Drs. Jessica Lin and Chul Kim discuss what treatment options are available for ROS1 and ALK cancer that transforms to a neuroendocrine tumor.
A huge thank you to our sponsors! #AstraZeneca #Novartis #lilly #blueprintmedicines #takedaoncology #boehringerIngelheim #genentech